Vimarsana
Biggest News Aggregation in the World

Page 22 - Genetic Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genetic Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genetic Technologies Today - Breaking & Trending Today

Opinion: Biodiversity Loss Worsened by Extinguishing Animal Innovators - Vimarsana News

Opinion: Biodiversity Loss Worsened by Extinguishing Animal Innovators

When species disappear, more than their genomes are lost. The potential for their creative innovation to benefit ecosystems vanishes as well.

Genetic Technologies Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report - Vimarsana News

Genetic Technologies Limited Interview to Air on Bloomberg U.S. on the RedChip Money Report

ORLANDO, FL / ACCESSWIRE / October 13, 2022 / RedChip Companies will air a new interview with Genetic Technologies Limited (ASX:GTG)(NASDAQ:GENE) ("Company", "GTG"), a global leader in genomics-based tests

Genetic Technologies Provides Update on US Operations and Payer Engagement - Vimarsana News

Genetic Technologies Provides Update on US Operations and Payer Engagement

MELBOURNE, Australia, Sept. 02, 2022 -- Genetic Technologies Limited , a global leader in guideline driven genomics-based tests in health, wellness and serious disease, is pleased to report... | September 2, 2022

Global Gene Therapy Market 2022-2027: Rising Funding for - Vimarsana News

Global Gene Therapy Market 2022-2027: Rising Funding for

Dublin, Aug. 12, 2022 (GLOBE NEWSWIRE) -- The "Global Gene Therapy Market by Vectors (Non-viral(Oligonucleotides), Viral(Retroviral, Adeno-associated)),...

Assenagon Asset Management S.A. Has $297,000 Position in Applied Genetic Technologies Co. (NASDAQ:AGTC) - Vimarsana News

Assenagon Asset Management S.A. Has $297,000 Position in Applied Genetic Technologies Co. (NASDAQ:AGTC)

Assenagon Asset Management S.A. lowered its stake in shares of Applied Genetic Technologies Co. (NASDAQ:AGTC – Get Rating) by 35.5% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 277,656 shares of the biotechnology company’s stock after selling 152,899 shares during the period. Assenagon […]